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OBJECTIVE: Most lung transplants are obtained from brain-dead donors. The physiopathology of brain death
involves hemodynamics, the sympathetic nervous system, and inflammatory mechanisms. Administering
methylprednisolone 60 min after inducing brain death in rats has been shown to modulate pulmonary
inflammatory activity. Our objective was to evaluate the effects of methylprednisolone on transplanted rat
lungs from donors treated 60 min after brain death.
METHODS: Twelve Wistar rats were anesthetized, and brain death was induced. They were randomly divided
into two groups (n = 6), namely a control group, which was administered saline solution, and a
methylprednisolone group, which received the drug 60 min after the induction of brain death. All of the
animals were observed and ventilated for 2 h prior to being submitted to lung transplantation. We evaluated
the hemodynamic and blood gas parameters, histological score, lung tissue levels of thiobarbituric acid-
reactive substances, level of superoxide dismutase, level of tumor necrosis factor-alpha, and level of interleukin-
1 beta.
RESULTS: After transplantation, a significant reduction in the levels of tumor necrosis factor-alpha and IL-1b was
observed in the group that received methylprednisolone (p=0.0084 and p=0.0155, respectively). There were no
significant differences in tumor necrosis factor-alpha and superoxide dismutase levels between the control and
methylprednisolone groups (p=0.2644 and p=0.7461, respectively). There were no significant differences in the
blood gas parameters, hemodynamics, and histological alterations between the groups.
CONCLUSION: The administration of methylprednisolone after brain death in donor rats reduces inflammatory
activity in transplanted lungs but has no influence on parameters related to oxidative stress.
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& INTRODUCTION
The availability of donor organs remains a challenge for
transplantation programs worldwide. This issue is a
particular problem for lung transplantation, which is the
ultimate option for patients with end-stage pulmonary
disease. Approximately 5%-20% of donors who elect for
organ retrieval have lungs that are considered viable for
lung transplantation. However, the number of patients
enrolled on waiting lists has been increasing (1-3).
Brain-dead donors still represent the main source of
organs for transplantation. It is well known that brain death
compromises the viability of transplanted solid organs, and
it can affect lung donor viability through sympathetic,
hemodynamic, and inflammatory mechanisms that lead to
adrenergic storm and neurogenic pulmonary edema (4). In
addition, these lungs are at risk for acute lung injury
secondary to trauma, prolonged mechanical ventilation,
transfusion, ischemia, aspiration, and infection (4,5).
Currently, there is mounting evidence to suggest that
organ grafts are not immunologically inert. Donor risk
factors, such as previous disease, age, cause of death, donor
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management, and, most importantly, brain death, repro-
gram the graft into an immunologically active organ (5).
Accordingly, treating potential brain-dead donors may
reduce immune activation and improve the condition of
the lung that is to be transplanted (6).
The administration of systemic corticosteroids to brain-
dead donors is known to be beneficial, mostly because it
modulates the systemic inflammatory response caused by
brain death (7). This modulation improves graft viability by
reducing both the release of pro-inflammatory molecules
and the production of leukocyte adhesion molecules,
thereby increasing the clearance of alveolar fluids (7,8).
However, the optimal timing of the administration of
corticosteroids during brain death remains unknown.
Previously, we showed that in a model of brain death, the
administration of methylprednisolone at 5 and 60 min
reduced the levels of TNF-a to a similar extent (9). In the
present study, we hypothesized that the transplanted lungs
from donors treated with methylprednisolone after 60 min
of brain death would exhibit less inflammatory activity than
those of untreated donors.
& MATERIALS AND METHODS
The Ethical and Research Committee of Hospital de
Clı´nicas de Porto Alegre approved the protocols used in this
study. All of the animals received humane care that was in
compliance with the Principles of Laboratory Animal Care
formulated by the National Society for Medical Research
and the Guide for the Care and Use of Laboratory Animals
(Institute of Laboratory Animal Resources, published by the
National Institutes of Health, Publication No. 86-23, revised
1996).
Surgical procedure
Twelve male rats, weighing 300-400 g each, underwent
general anesthesia induced by an intraperitoneal injection of
ketamine (100 mg/kg) and xylazine (15 mg/kg). Anesthesia
was followed by a tracheostomy using an indwelling 14-
gauge cannula (AbbocathH #14; Abbott Laboratories,
Abbott Park, IL, EUA) and ventilation at a rate of 70-80
breaths/min with a tidal volume of 10 ml/kg of inspired
room air (Harvard Rodent Ventilator, model 683; Harvard
Apparatus Co., Millis, MA). The right carotid artery was
dissected and cannulated using a 24-gauge cannula (Becton
Dickinson, Franklin Lakes, NJ, USA) to record the mean
arterial pressure (MAP) and heart rate (HR) (Sirecust 730
Siemens, Solna, Sweden). The right jugular vein was also
dissected and cannulated in the same manner. Normal
saline was used to flush the lines, with a total volume of
5 ml/kg/h used in all of the animals, and a warmed
surgical table was used to maintain the body temperature at
37 C˚ during the procedure.
Two hours following brain death, the donor rat lungs
were flushed in an antegrade manner with 20 ml of cold
(4 C˚), low-potassium dextran solution (LPD-PerfadexH;
Vitrolife, Go¨teborg, Sweden) at a pressure of 20 cmH2O
via the pulmonary artery, as described elsewhere (10). The
heart-lung block was extracted with the lungs inflated at the
end-tidal volume. The left lung graft was isolated, prepared,
and stored in LPD at 4 C˚ for 90 min.
Twelve recipients were anaesthetized, intubated (14-
gauge catheter), and ventilated. Then, they underwent a
left thoracotomy, and the pulmonary vessels and left
bronchus were anastomosed using a standard cuff techni-
que (10). The arterial clamps were released approximately
3 h after harvest. The recipient animals were then observed
for 2 h. At the end of the observation period, the pulmonary
hilum was clamped, and the lower half of the lung was
immediately snap-frozen in liquid nitrogen and stored at
280 C˚. The upper half of the lung was embedded in 10%
formaldehyde for histopathology.
Induction of brain death
The brain death model used here has previously been
described in detail (11,12). Briefly, a frontolateral trepana-
tion (161 mm with a dental drill) was performed, and a 14-
gauge Fogarty balloon catheter (Baxter Health Care Corp.,
Irvine, CA, USA) was introduced into the extradural space
with the tip pointed caudally. The balloon was inflated with
0.75 ml of water for 1 min, producing a sudden increase in
intracranial pressure, which resulted in rapid, progressive
brain injury leading to immediate brain death. A sharp rise,
followed by a subsequent drop, of blood pressure and heart
rate defined the initiation of brain death. The presence of
brain death was confirmed by the absence of corneal
reflexes and by the apnea test.
Study groups
After the initial procedures, the animals were randomly
assigned to two brain-dead donor groups, namely the
control (n = 6) and corticosteroid (n= 6) groups. In the
control group (CONTROL), an IV bolus of 0.9% saline
solution (0.3 ml) was administered 60 min after the induc-
tion of brain death. In the corticosteroid group (MET), an IV
bolus of methylprednisolone (30 mg/kg) diluted in 0.2 ml
of normal saline was administered 60 min after the
induction of brain death. The timing and dose of methyl-
prednisolone were based on a previous study (9).
Sampling
All of the donor and recipient animals were monitored for
120 min and were submitted to the same ventilation
procedures. Arterial blood samples were obtained at the
time of insertion of the arterial line (basal) and at 60 and
120 min in the donor groups. In the recipient groups, the
samples were drawn at 5 and 120 min after transplantation
for blood gas analysis.
The lower half of the left lung was snap-frozen in liquid
nitrogen and stored at 280 C˚ for analyses of lipid
peroxidation and superoxide dismutase (SOD) activity and
for the protein quantification of TNF-a and IL-1b (13).
Pulmonary TNF-a and IL-1b assay
After the samples were thawed, a 96-well plate was
coated with monoclonal antibodies against TNF-a and IL-
1b. The wells were filled with either 100 ml of homogenized
lung (diluted 152), 100 ml of positive or negative controls, or
100 ml of recombinant TNF-a or IL-1b at concentrations
established by the manufacturer (Creative Biomart, NY,
USA). Then, 100 ml of polyclonal anti-TNF-a and anti-IL-1b
conjugated to peroxidase was added to the wells, and the
samples were incubated for 3 h at room temperature.
Following the incubation, the plate was washed four times
with a detergent solution. The color change was then
induced by adding hydrogen peroxide (0.02%) and tetra-
methylbenzene (2%). The reaction was interrupted 30 min
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later using sulfuric acid (1 M). The color intensity was
assessed by obtaining optical density measurements using
an ELISA automatic reader (Titertek MultiskanH) at a
wavelength of 450 nm. The TNF-a and IL-1b concentrations
in the homogenized lung samples were calculated based on
the results of a standard curve.
Determination of thiobarbituric acid reactive
substances (TBARS)
The products generated by lipid peroxidation were
quantified by the TBARS reaction using 3 mg of protein
per sample. The samples were first incubated at 90 C˚ for
30 min. Then, 500 ml of 0.37% thiobarbituric acid and 15%
trichloroacetic acid was added to the samples, and they
were centrifuged at 4 C˚ at 2000xg for 15 min. The
absorbance was then determined by spectrophotometry at
535 nm (14).
Superoxide dismutase (SOD)
The activity of SOD was determined using the pulse
radiolytic method based on the auto-oxidation of epinephr-
ine, as described by Misra and Fridovich (15).
Histology
The portion of lung fixed in formalin was embedded in
paraffin, cut into 3-mm sections, and stained with hematox-
ylin and eosin. A pathologist blinded to the experimental
protocol performed a quantitative examination under light
microscopy. Each lung sample was examined under both
low- and high-power fields, and 20 fields were randomly
selected and analyzed. The severity of the histological
lesions was assigned a score based on five parameters,
namely intra-alveolar edema, hyaline membrane formation,
hemorrhage, focal alveolar collapse or consolidation, and
epithelial desquamation or the necrosis of airways or
alveoli. Each parameter was evaluated semi-quantitatively
according to the following scale: 0 = absent, 1 = mild, 2 =
moderate, and 3= prominent. For each animal, the scored
value of each parameter was added to produce a final score
(16).
Statistical analysis
All of the data collected from the experiments were
coded, recorded, and analyzed using SPSS 16.0 for
Windows (Chicago, IL, USA). To analyze the differences
in the demographic variables over time in each group, the
Wilcoxon nonparametric test was used. To analyze the
differences in the demographic variables between groups,
the Mann-Whitney U nonparametric test was used. For each
test, the data are expressed as the median ¡ the
interquartile range (IR), and p,0.05 was accepted as
statistically significant. For the cytokine, TBARS, SOD, and
histology analyses, the Student’s t-test was used; the data
are expressed as the mean value¡ standard error (SE), and
p,0.05 was accepted as statistically significant.
& RESULTS
There were no differences between the two groups with
respect to procedure time, blood gas measurements, and
mean arterial pressure. In the donor rats, the mean arterial
pressure decreased significantly in both groups after the
induction of brain death (p,0.05) (Table 1). There were no
differences between the two groups with respect to MAP
and blood gas analyses following transplantation (Table 2).
There were no significant differences in the results of the
TBARS and SOD assays between the MET and CONTROL
groups (p= 0.2644 and p= 0.7461, respectively). The TNF-a
and IL-1b tecidual concentrations were significantly lower
in the MET group (p= 0.0084 and p= 0.0155, respectively)
(Figures 1 and 2).
The severity of the histological damage, as measured by
the histology score (HIS), was similar between the
CONTROL and MET groups. The predominant finding
was mild focal alveolar collapse and congestion (Figure 3).
& DISCUSSION
While the early survival rates of patients after lung
transplantation have improved (1), their long-term survival
remains challenging (2,3). Immunological events are con-
sidered to be key factors in this scenario, and these events
may be aggravated by the alterations triggered by brain
death (17). The intensive care of potential donors may reflect
the outcome after transplantation, and the administration of
methylprednisolone has been suggested to be beneficial in
promoting organ maintenance in brain-dead donors (18).
Currently, the use of corticosteroids in potential donors
remains controversial, and there is no consensus regarding
the time of the first administration or the ideal dose required
to achieve an adequate anti-inflammatory effect (19). While
several studies have shown that resuscitative hormonal
protocols are promising, to date, no standard protocols for
lung retrieval have been accepted (19-20). The use of
corticosteroids in brain-dead donors is justified by two
potential beneficial effects, namely a reduction in the
inflammatory response and a replacement of the blood
hormonal levels. Faropoulos et al. observed that in a baboon
model, cortisol levels were reduced 15-45 min after the
Table 1 - The level of arterial blood gases and the mean arterial pressure in donor rats before and 2 h following brain
death.
Donors
Control Group Methylprednisolone Group
Baseline (median¡IR) 2 h after BD (median¡IR) p-value Baseline (median¡IR) 2 h after BD (median¡IR) p-value
PO2 84.53¡7.07 73.40¡26.42 0.48 100.28¡32.51 67.30¡17.95 0.055
PCO2 42.53¡14.68 44.38¡22.44 0.87 32.00¡6.27 37.10¡12.39 0.38
MAP 99.96¡28.47 54.07¡16.13 0.006* 89.68¡16.41 59.62¡10.73 0.003*
PaO2 = partial pressure of arterial oxygen; PaCO2 = partial pressure of arterial carbon dioxide; MAP = mean arterial pressure. Values are expressed as
the median ¡ interquartile of the median. * = statistical significance, as defined by p,0.05 according to the Mann-Whitney U test.
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induction of brain death and almost disappeared after
approximately 4 h (21).
In our previous study, we found that both the early
(5 min) and late (60 min) administration of methylpredni-
solone reduced TNF-a to levels similar to those present 2 h
after brain death. In the present study, we administered
methylprednisolone after 60 min of brain death to simulate
the clinical scenario, in which the prompt diagnosis of brain
death is usually delayed. We retrieved donor lungs after 2 h
of brain death, under the assumption that there was no
harmful impact on lung function until 5 h following brain
death (22). However, other studies have shown that 6 h is
the minimum elapsed time following brain death necessary
for the analysis of inflammatory mediators (23).
TNF-a is the main inflammatory mediator after brain
death. In addition to its direct participation in the inflamma-
tory process, it is also responsible for the activation of
apoptotic processes (24). Zhou HC et al. showed that carbon
monoxide inhalation reduced the expression of TNF-a, IL-6,
adhesion molecules, and pro-apoptotic pathways, improving
PaO2/FiO2 and the base excess and acidosis generated by
brain death (25). Our study showed that the administration of
a corticosteroid 1 h after brain death can reduce the
concentration of TNF-a, even after lung transplantation, thus
demonstrating its benefit in this scenario.
Several studies have measured IL-1b levels in models of
acute lung injury (26), brain death (27), and lung transplan-
tation (28). High levels of IL-1b have previously been
associated with acute lung injury and rejection (26). In our
study, we observed a significant decrease in IL-1b in the
transplanted lungs of brain-dead donors treated with
methylprednisolone, reflecting its potential protective anti-
inflammatory effect after lung reperfusion, which would
consequently reduce ischemia-reperfusion injury.
Cytokines released after brain injury are likely crucial
factors associated with the inflammatory activation that
takes place in peripheral organs. Severe cerebral injury leads
to the release of cytokines, such as TNF-a, IL-1b, and IL-6,
from astrocytes and microglial cells (29). These cytokines
cross the blood-brain barrier and reach peripheral organs
and tissues (30), resulting in the expression of IL-1, IL-2, IL-
6, TNF-a, and INF-c in these organs, as well as the lungs
(31). An experimental study that performed cross circula-
tion between controls and rats that underwent sudden brain
death revealed an elevation of levels of lymphocytic and
leukocyte inflammatory molecules (31).
Focal or generalized cerebral ischemia promotes the
release of IL-1b and TNF-a in the brain (32), which induces
the production of IL-6. It has been shown that patients in the
intensive care unit for cerebral trauma had higher IL-6 levels
in their jugular venous blood than their arterial blood (33).
A clinical study showed that patients with stroke exhibited
an elevated expression of IL-1b, IL-8, and IL-17 in peripheral
mononuclear cells and concluded that cerebral ischemia
stimulates the production of inflammatory cytokines in
peripheral leukocytes (34).
Table 2 - The levels of arterial blood gases and the mean arterial pressure in recipients at baseline and 2 h following
lung transplantation.
Recipients
Control Group Methylprednisolone Group p-value
PO2 Baseline (median¡IR) 226.27¡132.99 191.30¡88.49 0.631
After 2 h (median¡IR) 242.55¡138.15 288.98¡125.35 0.465
PCO2 Baseline (median¡IR) 44.87¡6.76 38.85¡9.88 0.297
After 2 h (median¡IR) 40.52¡19.76 56.74¡41.62 0.715
MAP Baseline (median¡IR) 88.67¡18.47 69.89¡16.75 0.077
After 2 h (median¡IR) 55.44¡19.74 60.72¡14.22 0.522
PaO2 = partial pressure of arterial oxygen; PaCO2 = partial pressure of arterial carbon dioxide; MAP = mean arterial pressure; #= Mann-Whitney U test.
Values are expressed as the median ¡ interquartile range of the median.
Figure 1 - Pulmonary tumor necrosis factor-alpha assay. After
transplantation, there was a significant decrease in the levels of
tumor necrosis factor-alpha in the methylprednisolone group
compared with the control group (*p=0.0084). The values are
expressed as the mean ¡ standard error of the mean.
Figure 2 - Pulmonary interleukin-1 beta assay. After transplanta-
tion, there was a significant decrease in the levels of interleukin-
1 beta in the methylprednisolone group compared with the
control group (*p=0.0155). The values are expressed as the
mean ¡ standard error of the mean.
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After brain death, hemodynamic events occur concomi-
tantly with systemic inflammatory events. This systemic
inflammatory response has been associated with the
production of cytokines by the brain. However, the precise
role of these cytokines and whether the inflammatory
response is due to central or peripheral factors are unclear
(35).
In this study, the administration of methylpredniso-
lone did not change hemodynamics and blood exchange
prior to and after transplantation, indicating that its
administration does not add any additional detrimental
effect, as was previously shown by Pilla et al. (9). In
contrast, Wigfield et al. showed that in a rat transplanta-
tion model, methylprednisolone treatment resulted in
better graft function and less inflammatory activity after
transplantation (8).
The present study has some limitations, and extrapolation
of our results to clinical scenarios should be carefully
performed. This study used a small, standardized animal
model that involved the induction of brain death by a
sudden increase in intracranial pressure. These conditions
do not always match the clinical situation because intracra-
nial pressure sometimes rises at a slow rate until brain death
is established. Thus, a brain death model that employs a
gradual rise of intracranial pressure may be more appro-
priate. Additionally, the interval between the establishment
of brain death and lung harvest was shorter than is common
in clinical practice. However, in our experimental model, we
tried to reduce all of the confounding factors that were
related to the time of preservation and that were detrimental
to lung function due to long periods of ventilation after
brain death.
We conclude that the administration of methylpredniso-
lone after 60 min of brain death in donor rats reduces
the inflammatory response after lung transplantation
and has no effect on lipid peroxidation activity. Further
studies with larger animals and models that better simulate
the clinical scenarios, such as a longer period of brain
death, a longer period prior to intervention, and a gradual
increase in the intracranial pressure, are needed to
confirm the beneficial effects of this treatment method. We
suggest that the administration of methylprednisolone in
potential multi-organ donors may be a useful strategy for
reducing the dangerous effects of reperfusion after lung
transplantation.
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